BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

364 related articles for article (PubMed ID: 30199814)

  • 1. Assessment of NICE and USPSTF guidelines for identifying women at high risk of pre-eclampsia for tailoring aspirin prophylaxis in pregnancy: An individual participant data meta-analysis.
    Al-Rubaie ZTA; Askie LM; Hudson HM; Ray JG; Jenkins G; Lord SJ
    Eur J Obstet Gynecol Reprod Biol; 2018 Oct; 229():159-166. PubMed ID: 30199814
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiplatelet agents for preventing and treating pre-eclampsia.
    Knight M; Duley L; Henderson-Smart DJ; King JF
    Cochrane Database Syst Rev; 2000; (2):CD000492. PubMed ID: 10796208
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prediction of pre-eclampsia in nulliparous women using routinely collected maternal characteristics: a model development and validation study.
    Al-Rubaie ZTA; Hudson HM; Jenkins G; Mahmoud I; Ray JG; Askie LM; Lord SJ
    BMC Pregnancy Childbirth; 2020 Jan; 20(1):23. PubMed ID: 31906891
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The performance of risk prediction models for pre-eclampsia using routinely collected maternal characteristics and comparison with models that include specialised tests and with clinical guideline decision rules: a systematic review.
    Al-Rubaie Z; Askie LM; Ray JG; Hudson HM; Lord SJ
    BJOG; 2016 Aug; 123(9):1441-52. PubMed ID: 27225348
    [TBL] [Abstract][Full Text] [Related]  

  • 5. WITHDRAWN: Antiplatelet agents for preventing and treating pre-eclampsia.
    Knight M; Duley L; Henderson-Smart DJ; King JF
    Cochrane Database Syst Rev; 2007 Jul; 2007(2):CD000492. PubMed ID: 17636639
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiplatelet agents for preventing pre-eclampsia and its complications.
    Duley L; Henderson-Smart DJ; Knight M; King JF
    Cochrane Database Syst Rev; 2004; (1):CD004659. PubMed ID: 14974075
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validation and development of models using clinical, biochemical and ultrasound markers for predicting pre-eclampsia: an individual participant data meta-analysis.
    Allotey J; Snell KI; Smuk M; Hooper R; Chan CL; Ahmed A; Chappell LC; von Dadelszen P; Dodds J; Green M; Kenny L; Khalil A; Khan KS; Mol BW; Myers J; Poston L; Thilaganathan B; Staff AC; Smith GC; Ganzevoort W; Laivuori H; Odibo AO; Ramírez JA; Kingdom J; Daskalakis G; Farrar D; Baschat AA; Seed PT; Prefumo F; da Silva Costa F; Groen H; Audibert F; Masse J; Skråstad RB; Salvesen KÅ; Haavaldsen C; Nagata C; Rumbold AR; Heinonen S; Askie LM; Smits LJ; Vinter CA; Magnus PM; Eero K; Villa PM; Jenum AK; Andersen LB; Norman JE; Ohkuchi A; Eskild A; Bhattacharya S; McAuliffe FM; Galindo A; Herraiz I; Carbillon L; Klipstein-Grobusch K; Yeo S; Teede HJ; Browne JL; Moons KG; Riley RD; Thangaratinam S
    Health Technol Assess; 2020 Dec; 24(72):1-252. PubMed ID: 33336645
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiplatelet agents for preventing pre-eclampsia and its complications.
    Duley L; Henderson-Smart DJ; Meher S; King JF
    Cochrane Database Syst Rev; 2007 Apr; (2):CD004659. PubMed ID: 17443552
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aspirin non-responsiveness in pregnant women at high-risk of pre-eclampsia.
    Navaratnam K; Alfirevic A; Jorgensen A; Alfirevic Z
    Eur J Obstet Gynecol Reprod Biol; 2018 Feb; 221():144-150. PubMed ID: 29304392
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aspirin in the prevention of pre-eclampsia in high-risk women: a randomised placebo-controlled PREDO Trial and a meta-analysis of randomised trials.
    Villa PM; Kajantie E; Räikkönen K; Pesonen AK; Hämäläinen E; Vainio M; Taipale P; Laivuori H;
    BJOG; 2013 Jan; 120(1):64-74. PubMed ID: 23126307
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of diagnostic accuracy of early screening for pre-eclampsia by NICE guidelines and a method combining maternal factors and biomarkers: results of SPREE.
    Tan MY; Wright D; Syngelaki A; Akolekar R; Cicero S; Janga D; Singh M; Greco E; Wright A; Maclagan K; Poon LC; Nicolaides KH
    Ultrasound Obstet Gynecol; 2018 Jun; 51(6):743-750. PubMed ID: 29536574
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Barbados Low Dose Aspirin Study in Pregnancy (BLASP): a randomised trial for the prevention of pre-eclampsia and its complications.
    Rotchell YE; Cruickshank JK; Gay MP; Griffiths J; Stewart A; Farrell B; Ayers S; Hennis A; Grant A; Duley L; Collins R
    Br J Obstet Gynaecol; 1998 Mar; 105(3):286-92. PubMed ID: 9532988
    [TBL] [Abstract][Full Text] [Related]  

  • 13. First-trimester prediction of preterm pre-eclampsia and prophylaxis by aspirin: Effect on spontaneous and iatrogenic preterm birth.
    Nicolaides KH; Syngelaki A; Poon LC; Rolnik DL; Tan MY; Wright A; Wright D
    BJOG; 2024 Mar; 131(4):483-492. PubMed ID: 37749709
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    Mone F; Mulcahy C; McParland P; Breathnach F; Downey P; McCormack D; Culliton M; Stanton A; Cody F; Morrison JJ; Daly S; Higgins J; Cotter A; Hunter A; Tully EC; Dicker P; Alfirevic Z; Malone FD; McAuliffe FM
    BMJ Open; 2018 Jul; 8(7):e022056. PubMed ID: 30056389
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Implementation of routine first trimester combined screening for pre-eclampsia: a clinical effectiveness study.
    Guy GP; Leslie K; Diaz Gomez D; Forenc K; Buck E; Khalil A; Thilaganathan B
    BJOG; 2021 Jan; 128(2):149-156. PubMed ID: 32613730
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiplatelet agents for prevention of pre-eclampsia: a meta-analysis of individual patient data.
    Askie LM; Duley L; Henderson-Smart DJ; Stewart LA;
    Lancet; 2007 May; 369(9575):1791-1798. PubMed ID: 17512048
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevention of pre-eclampsia with low-dose aspirin or vitamins C and E in women at high or low risk: a systematic review with meta-analysis.
    Rossi AC; Mullin PM
    Eur J Obstet Gynecol Reprod Biol; 2011 Sep; 158(1):9-16. PubMed ID: 21641104
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiplatelet therapy before or after 16 weeks' gestation for preventing preeclampsia: an individual participant data meta-analysis.
    Meher S; Duley L; Hunter K; Askie L
    Am J Obstet Gynecol; 2017 Feb; 216(2):121-128.e2. PubMed ID: 27810551
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiplatelet drugs for prevention of pre-eclampsia and its consequences: systematic review.
    Duley L; Henderson-Smart D; Knight M; King J
    BMJ; 2001 Feb; 322(7282):329-33. PubMed ID: 11159655
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 19.